These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 23422726)

  • 1. Pancreatic cancer-associated Cathepsin E as a drug activator.
    Abd-Elgaliel WR; Cruz-Monserrate Z; Wang H; Logsdon CD; Tung CH
    J Control Release; 2013 May; 167(3):221-7. PubMed ID: 23422726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of pancreatic cancer tumours and precursor lesions by cathepsin E activity in mouse models.
    Cruz-Monserrate Z; Abd-Elgaliel WR; Grote T; Deng D; Ji B; Arumugam T; Wang H; Tung CH; Logsdon CD
    Gut; 2012 Sep; 61(9):1315-22. PubMed ID: 22068166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of active targeting, enzyme-triggered release and fluorescent dye into gold nanoclusters for endomicroscopy-guided photothermal/photodynamic therapy to pancreatic ductal adenocarcinoma.
    Li H; Wang P; Deng Y; Zeng M; Tang Y; Zhu WH; Cheng Y
    Biomaterials; 2017 Sep; 139():30-38. PubMed ID: 28582716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulating ALA-PDT efficacy of mutlidrug resistant MCF-7 breast cancer cells using ALA prodrug.
    Feuerstein T; Berkovitch-Luria G; Nudelman A; Rephaeli A; Malik Z
    Photochem Photobiol Sci; 2011 Dec; 10(12):1926-33. PubMed ID: 22020364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precise Photodynamic Therapy by Midkine Nanobody-Engineered Nanoparticles Remodels the Microenvironment of Pancreatic Ductal Adenocarcinoma and Potentiates the Immunotherapy.
    Qu C; Yuan H; Tian M; Zhang X; Xia P; Shi G; Hou R; Li J; Jiang H; Yang Z; Chen T; Li Z; Wang J; Yuan Y
    ACS Nano; 2024 Feb; 18(5):4019-4037. PubMed ID: 38253029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zwitterionic stealth peptide-capped 5-aminolevulinic acid prodrug nanoparticles for targeted photodynamic therapy.
    Wu J; Lin Y; Li H; Jin Q; Ji J
    J Colloid Interface Sci; 2017 Jan; 485():251-259. PubMed ID: 27676086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Light-Activated Monomethyl Auristatin E Prodrug Nanoparticles for Combinational Photo-Chemotherapy of Pancreatic Cancer.
    Cho IK; Shim MK; Um W; Kim JH; Kim K
    Molecules; 2022 Apr; 27(8):. PubMed ID: 35458727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast Activation Protein-Targeted Photodynamic Therapy of Cancer-Associated Fibroblasts in Murine Models for Pancreatic Ductal Adenocarcinoma.
    Dorst DN; Smeets EMM; Klein C; Frielink C; Geijs D; Trajkovic-Arsic M; Cheung PFY; Stommel MWJ; Gotthardt M; Siveke JT; Aarntzen EHJG; van Lith SAM
    Mol Pharm; 2023 Aug; 20(8):4319-4330. PubMed ID: 37485886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide-targeted dendrimeric prodrugs of 5-aminolevulinic acid: A novel approach towards enhanced accumulation of protoporphyrin IX for photodynamic therapy.
    Tewari KM; Dondi R; Yaghini E; Pourzand C; MacRobert AJ; Eggleston IM
    Bioorg Chem; 2021 Apr; 109():104667. PubMed ID: 33611140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifunctional 5-aminolevulinic acid prodrugs activating diverse cell-death pathways.
    Berkovitch-Luria G; Weitman M; Nudelman A; Rephaeli A; Malik Z
    Invest New Drugs; 2012 Jun; 30(3):1028-38. PubMed ID: 21509470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Serotonin Signaling Contributes to the Warburg Effect in Pancreatic Tumor Cells Under Metabolic Stress and Promotes Growth of Pancreatic Tumors in Mice.
    Jiang SH; Li J; Dong FY; Yang JY; Liu DJ; Yang XM; Wang YH; Yang MW; Fu XL; Zhang XX; Li Q; Pang XF; Huo YM; Li J; Zhang JF; Lee HY; Lee SJ; Qin WX; Gu JR; Sun YW; Zhang ZG
    Gastroenterology; 2017 Jul; 153(1):277-291.e19. PubMed ID: 28315323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-aminolaevulinic acid and photodynamic therapy reduce HSV-1 replication in HaCat cells through an apoptosis-independent mechanism.
    Ayala F; Grimaldi E; Perfetto B; Donnarumma M; De Filippis A; Donnarumma G; Tufano MA
    Photodermatol Photoimmunol Photomed; 2008 Oct; 24(5):237-43. PubMed ID: 18811864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving in vitro photodynamic therapy through the development of a novel iron chelating aminolaevulinic acid prodrug.
    Curnow A; Perry A; Wood M
    Photodiagnosis Photodyn Ther; 2019 Mar; 25():157-165. PubMed ID: 30553949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cathepsin E expression and activity: Role in the detection and treatment of pancreatic cancer.
    Pontious C; Kaul S; Hong M; Hart PA; Krishna SG; Lara LF; Conwell DL; Cruz-Monserrate Z
    Pancreatology; 2019 Oct; 19(7):951-956. PubMed ID: 31582345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL6 Receptor Blockade Enhances Chemotherapy Efficacy in Pancreatic Ductal Adenocarcinoma.
    Long KB; Tooker G; Tooker E; Luque SL; Lee JW; Pan X; Beatty GL
    Mol Cancer Ther; 2017 Sep; 16(9):1898-1908. PubMed ID: 28611107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly(L-histidine)-tagged 5-aminolevulinic acid prodrugs: new photosensitizing precursors of protoporphyrin IX for photodynamic colon cancer therapy.
    Johnson RP; Chung CW; Jeong YI; Kang DH; Suh H; Kim I
    Int J Nanomedicine; 2012; 7():2497-512. PubMed ID: 22679363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting cathepsin E in pancreatic cancer by a small molecule allows in vivo detection.
    Keliher EJ; Reiner T; Earley S; Klubnick J; Tassa C; Lee AJ; Ramaswamy S; Bardeesy N; Hanahan D; Depinho RA; Castro CM; Weissleder R
    Neoplasia; 2013 Jul; 15(7):684-93. PubMed ID: 23814481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of phosphatase-sensitive 5-aminolevulinic acid prodrugs in cancer cell lines.
    Herceg V; Lange N; Allémann E; Babič A
    J Photochem Photobiol B; 2017 Jun; 171():34-42. PubMed ID: 28472723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of angiotensin II type 2 receptor (AT2R) signaling in human pancreatic ductal adenocarcinoma (PDAC): a novel AT2R agonist effectively attenuates growth of PDAC grafts in mice.
    Ishiguro S; Yoshimura K; Tsunedomi R; Oka M; Takao S; Inui M; Kawabata A; Wall T; Magafa V; Cordopatis P; Tzakos AG; Tamura M
    Cancer Biol Ther; 2015; 16(2):307-16. PubMed ID: 25756513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer-Specific Targeting of Taurine-Upregulated Gene 1 Enhances the Effects of Chemotherapy in Pancreatic Cancer.
    Tasaki Y; Suzuki M; Katsushima K; Shinjo K; Iijima K; Murofushi Y; Naiki-Ito A; Hayashi K; Qiu C; Takahashi A; Tanaka Y; Kawaguchi T; Sugawara M; Kataoka T; Naito M; Miyata K; Kataoka K; Noda T; Gao W; Kataoka H; Takahashi S; Kimura K; Kondo Y
    Cancer Res; 2021 Apr; 81(7):1654-1666. PubMed ID: 33648930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.